204 related articles for article (PubMed ID: 34913991)
1. Prediction of prostate cancer grade using fractal analysis of perfusion MRI: retrospective proof-of-principle study.
Michallek F; Huisman H; Hamm B; Elezkurtaj S; Maxeiner A; Dewey M
Eur Radiol; 2022 May; 32(5):3236-3247. PubMed ID: 34913991
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of fractal analysis and PI-RADS assessment of prostate magnetic resonance imaging for prediction of cancer grade groups: a clinical validation study.
Michallek F; Huisman H; Hamm B; Elezkurtaj S; Maxeiner A; Dewey M
Eur Radiol; 2022 Apr; 32(4):2372-2383. PubMed ID: 34921618
[TBL] [Abstract][Full Text] [Related]
3. Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups.
Bakir B; Onay A; Vural M; Armutlu A; Yıldız SÖ; Esen T
AJR Am J Roentgenol; 2020 Mar; 214(3):588-596. PubMed ID: 31670596
[No Abstract] [Full Text] [Related]
4. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
[TBL] [Abstract][Full Text] [Related]
5. MRI grading for the prediction of prostate cancer aggressiveness.
Boschheidgen M; Schimmöller L; Arsov C; Ziayee F; Morawitz J; Valentin B; Radke KL; Giessing M; Esposito I; Albers P; Antoch G; Ullrich T
Eur Radiol; 2022 Apr; 32(4):2351-2359. PubMed ID: 34748064
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of
Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
[TBL] [Abstract][Full Text] [Related]
7. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
9. The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone.
Chen Z; Xue Y; Zhang Z; Li W; Wen M; Zhao Y; Li J; Weng Z; Ye Q
Eur J Radiol; 2020 Apr; 125():108865. PubMed ID: 32058895
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of integrated
Zeng Y; Leng X; Liao H; Jiang G; Chen P
Prostate Int; 2022 Jun; 10(2):108-116. PubMed ID: 35510079
[TBL] [Abstract][Full Text] [Related]
11. A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy.
Pal RP; Ahmad R; Trecartan S; Voss J; Ahmed S; Bazo A; Lloyd J; Walton TJ
J Urol; 2018 Aug; 200(2):302-308. PubMed ID: 29477717
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
13. Prospective Inclusion of Apparent Diffusion Coefficients in Multiparametric Prostate MRI Structured Reports: Discrimination of Clinically Insignificant and Significant Cancers.
Costa DN; Xi Y; Aziz M; Passoni N; Shakir N; Goldberg K; Francis F; Roehrborn CG; Leon AD; Pedrosa I
AJR Am J Roentgenol; 2019 Jan; 212(1):109-116. PubMed ID: 30383404
[TBL] [Abstract][Full Text] [Related]
14. [Correlation analysis between prostate imaging report and data system score and pathological results of prostate cancer].
Zhu LY; Ding XF; Huang TB; Luan Y; Guo CH; Xu YZ; Wang F
Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(34):2663-2668. PubMed ID: 32921014
[No Abstract] [Full Text] [Related]
15. Magnetic resonance imaging-based 3-dimensional fractal dimension and lacunarity analyses may predict the meningioma grade.
Park YW; Kim S; Ahn SS; Han K; Kang SG; Chang JH; Kim SH; Lee SK; Park SH
Eur Radiol; 2020 Aug; 30(8):4615-4622. PubMed ID: 32274524
[TBL] [Abstract][Full Text] [Related]
16. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
[TBL] [Abstract][Full Text] [Related]
17. Characterization of high-grade prostate cancer at multiparametric MRI using a radiomic-based computer-aided diagnosis system as standalone and second reader.
Jaouen T; Souchon R; Moldovan PC; Bratan F; Duran A; Hoang-Dinh A; Di Franco F; Debeer S; Dubreuil-Chambardel M; Arfi N; Ruffion A; Colombel M; Crouzet S; Gonindard-Melodelima C; Rouvière O
Diagn Interv Imaging; 2023 Oct; 104(10):465-476. PubMed ID: 37345961
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
Lim CS; Abreu-Gomez J; Carrion I; Schieda N
AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
[No Abstract] [Full Text] [Related]
19. Detection of ISUP ≥2 prostate cancers using multiparametric MRI: prospective multicentre assessment of the non-inferiority of an artificial intelligence system as compared to the PI-RADS V.2.1 score (CHANGE study).
Rouvière O; Souchon R; Lartizien C; Mansuy A; Magaud L; Colom M; Dubreuil-Chambardel M; Debeer S; Jaouen T; Duran A; Rippert P; Riche B; Monini C; Vlaeminck-Guillem V; Haesebaert J; Rabilloud M; Crouzet S
BMJ Open; 2022 Feb; 12(2):e051274. PubMed ID: 35140147
[TBL] [Abstract][Full Text] [Related]
20. Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection.
Draulans C; Everaerts W; Isebaert S; Van Bruwaene S; Gevaert T; Oyen R; Joniau S; Lerut E; De Wever L; Laenen A; Weynand B; Defraene G; Vanhoutte E; De Meerleer G; Haustermans K
J Urol; 2020 Apr; 203(4):713-718. PubMed ID: 31718396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
